Compare BVS & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BVS | MAGN |
|---|---|---|
| Founded | 2011 | 1864 |
| Country | United States | United States |
| Employees | N/A | 8500 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 617.1M | 316.5M |
| IPO Year | 2016 | N/A |
| Metric | BVS | MAGN |
|---|---|---|
| Price | $9.97 | $10.65 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | ★ $14.00 | $12.00 |
| AVG Volume (30 Days) | 410.7K | ★ 497.1K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 163.46 | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $568,087,000.00 | N/A |
| Revenue This Year | $7.52 | $5.37 |
| Revenue Next Year | $7.06 | $3.47 |
| P/E Ratio | $28.56 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.81 | $7.82 |
| 52 Week High | $9.53 | $15.52 |
| Indicator | BVS | MAGN |
|---|---|---|
| Relative Strength Index (RSI) | 69.02 | 55.56 |
| Support Level | $8.43 | $10.52 |
| Resistance Level | N/A | $12.09 |
| Average True Range (ATR) | 0.35 | 0.44 |
| MACD | 0.05 | 0.28 |
| Stochastic Oscillator | 100.00 | 100.00 |
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.